Townsquare Capital LLC Has $5.75 Million Holdings in Colgate-Palmolive (NYSE:CL)

Townsquare Capital LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 111.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,350 shares of the company’s stock after acquiring an additional 29,157 shares during the quarter. Townsquare Capital LLC’s holdings in Colgate-Palmolive were worth $5,746,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. B. Riley Wealth Advisors Inc. grew its position in shares of Colgate-Palmolive by 0.8% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock worth $1,498,000 after buying an additional 138 shares during the period. Atria Investments Inc grew its position in shares of Colgate-Palmolive by 3.2% during the 1st quarter. Atria Investments Inc now owns 67,625 shares of the company’s stock worth $6,090,000 after buying an additional 2,115 shares during the period. Burney Co. grew its position in shares of Colgate-Palmolive by 11.0% during the 1st quarter. Burney Co. now owns 21,813 shares of the company’s stock worth $1,964,000 after buying an additional 2,160 shares during the period. Cetera Investment Advisers grew its position in shares of Colgate-Palmolive by 254.0% during the 1st quarter. Cetera Investment Advisers now owns 149,180 shares of the company’s stock worth $13,434,000 after buying an additional 107,041 shares during the period. Finally, Cetera Advisors LLC grew its position in shares of Colgate-Palmolive by 105.3% during the 1st quarter. Cetera Advisors LLC now owns 49,362 shares of the company’s stock worth $4,445,000 after buying an additional 25,315 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CL. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. UBS Group lifted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday. Finally, Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Price Performance

Shares of CL opened at $96.76 on Friday. The company has a market cap of $79.05 billion, a price-to-earnings ratio of 27.73, a PEG ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The company’s fifty day simple moving average is $97.51 and its 200 day simple moving average is $98.57. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.